54887-30-8: Clindamycin Phosphate EP Impurity D
It is a Clindamycin-related product. Clindamycin is a widely evaluated drug and an important alternative antibiotic in the therapy of Staphylococcus aureus, especially in methicillin-resistant S. aureus (MRSA) infections. Clindamycin resistance is high, approximately 63%.
Additional information on CAS 54887-30-8
methyl 7-chloro-6, 7, 8-trideoxy-6-[[[(2S, 4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-4-O-phosphono-1-thio-L-threo-α-D-galacto-octopyranoside
Davoudi, Mojtaba, et al. “ELECTROCHEMICAL DEGRADATION of CLINDAMYCIN by ANODIC OXIDATION on SnO2-Sb COATED TITANIUM ANODES.” Environmental Engineering and Management Journal, vol. 17, no. 2, 2018, pp. 343–55, https://doi.org/10.30638/eemj.2018.036. Ajantha, GS, et al. “Phenotypic Detection of Inducible Clindamycin Resistance among Staphylococcus Aureus Isolates by Using the Lower Limit of Recommended Inter-Disk Distance.” Indian Journal of Pathology and Microbiology, vol. 51, no. 3, 2008, p. 376, https://doi.org/10.4103/0377-4929.42515.
Other products related to clindamycin
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|